s6y
Company name or ticker
Search
SUTRO BIOPHARMA, INC.
4
Sharp Shalini: Statement of changes in beneficial ownership of securities
Filed
Wednesday, June 8, 2022
Period
Jun 6, 2022
Accession number
0001209191-22-035212
Documents
FORM 4 SUBMISSION
4
On sec.gov
Filing index
All files
Complete submission text
SGML header